Long-term lithium treatment prevents neurotoxic effects of β-bungarotoxin in primary cultured neurons

Wen-Pei Tseng, Shoei Yn Lin-Shiau

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Lithium is the most commonly used drug for the treatment of manic-depressive illness. The precise mechanisms underlying its clinical efficacy remain unknown. In this study, we found that long-term exposure to lithium chloride protected cultured cerebellar granule neurons (CGNs) against β-bungarotoxin (β-BuTX)-induced neurotoxicity. This neuroprotection was exhibited at the therapeutically relevant concentration of 1.2 mM lithium. Pretreatments for 3-5 days (long-term) were required for protection to occur; but a 3 hr treatment (short-term) was ineffective. In contrast, a longer treatment for 6-7 days or a higher concentration of 3 mM lithium led not only to loss of the neuroprotective effect but also to a neurotoxic effect. These findings suggest that lithium protection is limited to its narrow window of concentration and apparently relevant to its narrow therapeutic index in clinical application. Measurement of intracellular calcium [Ca2+]i revealed that neurotoxic concentrations of β-BuTX markedly increased [Ca2+]i, which could be attenuated by long-term, but not short-term, lithium treatment. Thus, the protection induced by lithium in CGNs was attributed to its inhibition of calcium overload. In addition, the Ca2+ signaling pathway, including reactive oxygen species production and mitochondrial membrane potential reduction, along with the neurotoxic effect of β-BuTX was blocked by long-term, but not short-term, lithium treatment. All of these results indicate that a crucial step for lithium protection is modulation of [Ca2+]i homeostasis and that lithium neurotoxicity possibly, at least in part, is due to calcium overload. In conclusion, our results suggest that lithium, in addition to its use in treatment of bipolar depressive illness, may have an expanded use in intervention for neurotoxicity.

Original languageEnglish
Pages (from-to)633-641
Number of pages9
JournalJournal of Neuroscience Research
Volume69
Issue number5
DOIs
Publication statusPublished - 2002 Sep 1

Fingerprint

Bungarotoxins
Lithium
Neurons
Calcium
Lithium Chloride
Mitochondrial Membrane Potential
Neuroprotective Agents
Reactive Oxygen Species
Homeostasis

All Science Journal Classification (ASJC) codes

  • Cellular and Molecular Neuroscience

Cite this

@article{1e55ea8e93724daa91097b98bbf969e6,
title = "Long-term lithium treatment prevents neurotoxic effects of β-bungarotoxin in primary cultured neurons",
abstract = "Lithium is the most commonly used drug for the treatment of manic-depressive illness. The precise mechanisms underlying its clinical efficacy remain unknown. In this study, we found that long-term exposure to lithium chloride protected cultured cerebellar granule neurons (CGNs) against β-bungarotoxin (β-BuTX)-induced neurotoxicity. This neuroprotection was exhibited at the therapeutically relevant concentration of 1.2 mM lithium. Pretreatments for 3-5 days (long-term) were required for protection to occur; but a 3 hr treatment (short-term) was ineffective. In contrast, a longer treatment for 6-7 days or a higher concentration of 3 mM lithium led not only to loss of the neuroprotective effect but also to a neurotoxic effect. These findings suggest that lithium protection is limited to its narrow window of concentration and apparently relevant to its narrow therapeutic index in clinical application. Measurement of intracellular calcium [Ca2+]i revealed that neurotoxic concentrations of β-BuTX markedly increased [Ca2+]i, which could be attenuated by long-term, but not short-term, lithium treatment. Thus, the protection induced by lithium in CGNs was attributed to its inhibition of calcium overload. In addition, the Ca2+ signaling pathway, including reactive oxygen species production and mitochondrial membrane potential reduction, along with the neurotoxic effect of β-BuTX was blocked by long-term, but not short-term, lithium treatment. All of these results indicate that a crucial step for lithium protection is modulation of [Ca2+]i homeostasis and that lithium neurotoxicity possibly, at least in part, is due to calcium overload. In conclusion, our results suggest that lithium, in addition to its use in treatment of bipolar depressive illness, may have an expanded use in intervention for neurotoxicity.",
author = "Wen-Pei Tseng and Lin-Shiau, {Shoei Yn}",
year = "2002",
month = "9",
day = "1",
doi = "10.1002/jnr.10318",
language = "English",
volume = "69",
pages = "633--641",
journal = "Journal of Neuroscience Research",
issn = "0360-4012",
publisher = "Wiley-Liss Inc.",
number = "5",

}

Long-term lithium treatment prevents neurotoxic effects of β-bungarotoxin in primary cultured neurons. / Tseng, Wen-Pei; Lin-Shiau, Shoei Yn.

In: Journal of Neuroscience Research, Vol. 69, No. 5, 01.09.2002, p. 633-641.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Long-term lithium treatment prevents neurotoxic effects of β-bungarotoxin in primary cultured neurons

AU - Tseng, Wen-Pei

AU - Lin-Shiau, Shoei Yn

PY - 2002/9/1

Y1 - 2002/9/1

N2 - Lithium is the most commonly used drug for the treatment of manic-depressive illness. The precise mechanisms underlying its clinical efficacy remain unknown. In this study, we found that long-term exposure to lithium chloride protected cultured cerebellar granule neurons (CGNs) against β-bungarotoxin (β-BuTX)-induced neurotoxicity. This neuroprotection was exhibited at the therapeutically relevant concentration of 1.2 mM lithium. Pretreatments for 3-5 days (long-term) were required for protection to occur; but a 3 hr treatment (short-term) was ineffective. In contrast, a longer treatment for 6-7 days or a higher concentration of 3 mM lithium led not only to loss of the neuroprotective effect but also to a neurotoxic effect. These findings suggest that lithium protection is limited to its narrow window of concentration and apparently relevant to its narrow therapeutic index in clinical application. Measurement of intracellular calcium [Ca2+]i revealed that neurotoxic concentrations of β-BuTX markedly increased [Ca2+]i, which could be attenuated by long-term, but not short-term, lithium treatment. Thus, the protection induced by lithium in CGNs was attributed to its inhibition of calcium overload. In addition, the Ca2+ signaling pathway, including reactive oxygen species production and mitochondrial membrane potential reduction, along with the neurotoxic effect of β-BuTX was blocked by long-term, but not short-term, lithium treatment. All of these results indicate that a crucial step for lithium protection is modulation of [Ca2+]i homeostasis and that lithium neurotoxicity possibly, at least in part, is due to calcium overload. In conclusion, our results suggest that lithium, in addition to its use in treatment of bipolar depressive illness, may have an expanded use in intervention for neurotoxicity.

AB - Lithium is the most commonly used drug for the treatment of manic-depressive illness. The precise mechanisms underlying its clinical efficacy remain unknown. In this study, we found that long-term exposure to lithium chloride protected cultured cerebellar granule neurons (CGNs) against β-bungarotoxin (β-BuTX)-induced neurotoxicity. This neuroprotection was exhibited at the therapeutically relevant concentration of 1.2 mM lithium. Pretreatments for 3-5 days (long-term) were required for protection to occur; but a 3 hr treatment (short-term) was ineffective. In contrast, a longer treatment for 6-7 days or a higher concentration of 3 mM lithium led not only to loss of the neuroprotective effect but also to a neurotoxic effect. These findings suggest that lithium protection is limited to its narrow window of concentration and apparently relevant to its narrow therapeutic index in clinical application. Measurement of intracellular calcium [Ca2+]i revealed that neurotoxic concentrations of β-BuTX markedly increased [Ca2+]i, which could be attenuated by long-term, but not short-term, lithium treatment. Thus, the protection induced by lithium in CGNs was attributed to its inhibition of calcium overload. In addition, the Ca2+ signaling pathway, including reactive oxygen species production and mitochondrial membrane potential reduction, along with the neurotoxic effect of β-BuTX was blocked by long-term, but not short-term, lithium treatment. All of these results indicate that a crucial step for lithium protection is modulation of [Ca2+]i homeostasis and that lithium neurotoxicity possibly, at least in part, is due to calcium overload. In conclusion, our results suggest that lithium, in addition to its use in treatment of bipolar depressive illness, may have an expanded use in intervention for neurotoxicity.

UR - http://www.scopus.com/inward/record.url?scp=0036708175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036708175&partnerID=8YFLogxK

U2 - 10.1002/jnr.10318

DO - 10.1002/jnr.10318

M3 - Article

C2 - 12210829

AN - SCOPUS:0036708175

VL - 69

SP - 633

EP - 641

JO - Journal of Neuroscience Research

JF - Journal of Neuroscience Research

SN - 0360-4012

IS - 5

ER -